You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 18, May 12, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the Clinical Center of the National Institutes of Health
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (25)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Arrhythmias
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic

Advances in Molecular Genetics and Management of Hypertrophic Cardiomyopathy

Lameh Fananapazir, MD, FRCP

JAMA. 1999;281:1746-1752.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

CASE PRESENTATION

A 28-year-old woman was diagnosed as having obstructive hypertrophic cardiomyopathy (HCM) during a family screening 13 years ago. The patient was initially treated with atenolol and verapamil for chest pain, but after several years, she complained of increasing angina and dyspnea. Physical examination revealed a prominent apical impulse and a grade 2/6 precordial systolic murmur. The 12-lead electrocardiogram showed sinus rhythm at 79/min, PR interval of 205 milliseconds, normal QRS axis, and left ventricular (LV) hypertrophy plus associated ST-T wave changes. The echocardiogram showed a septal thickness of 19 mm (normal, <=11 mm); LV free wall, 15 mm (normal, <11 mm); left atrium, 52 mm (normal, <40 mm); no systolic anterior motion of the mitral valve, but apposition of LV walls at the level of papillary muscles; mild mitral regurgitation; and predicted LV gradient of 85 mm Hg at rest. A cardiac magnetic resonance imaging study . . . [Full Text of this Article]

DISCUSSION

Clinical and Genetic Heterogeneity

Clinical Correlates of Genetic Defects

Gene-Specific Cardiac Morphology.

Mutation-Specific Penetrance and Natural History.

Mutation-Specific Etiologies of Sudden Death.

Mutation-Specific Functional Abnormalities.

Mutation-Specific Skeletal Myopathy.

Cardiac Hypertrophy as a Compensatory Mechanism

Theoretical Strategies to Induce Regression of Cardiac Disease

Risk Evaluation and Mechanisms of Sudden Death

Management of Arrhythmias

Management of Obstructive HCM

CONCLUSION

Author Affiliation: Section of Clinical Electrophysiology and Inherited Cardiac Diseases, Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.


RELATED LETTER

Hypertrophic Cardiomyopathy
Barry J. Maron, William J. McKenna, Perry Elliott, Paolo Spirito, Michael P. Frenneaux, Andre Keren, Franco Cecchi, Martin Borggrefe, William G. Williams, and Lameh Fananapazir
JAMA. 1999;282(24):2302-2303.
EXTRACT | FULL TEXT  

RELATED ARTICLE

May 12, 1999
JAMA. 1999;281(18):1765-1766.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.